Vaccination with a BCG Strain Overexpressing Ag85B Protects Cattle against Mycobacterium bovis Challenge

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Rizzi, Caroline ^a   Bianco, María Verónica ^b   Blanco, Federico Carlos ^b   Soria, Marcelo ^c   Gravisaco, María José ^b   Montenegro, Valeria ^b   Vagnoni, Lucas ^b   Buddle, Bryce ^d   Garbaccio, Sergio ^b   Delgado, Fernando ^b   Leal, Karen Silva ^a   Cataldi, Angel Adrián ^b   Dellagostin, Odir Antônio ^a   Bigi, Fabiana ^b  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^b INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^c Universidad de Buenos Aires   (Argentina)

^d AGRESEARCH GRASSLANDS   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BCG 85B VACCINE; BCG VACCINE; INTERLEUKIN 17; INTERLEUKIN 4; LEUCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BCG VACCINATION; BOVINE TUBERCULOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE SEVERITY; GENE OVEREXPRESSION; GENETIC COMPLEMENTATION; INFECTION CONTROL; INFECTION PREVENTION; MYCOBACTERIUM BOVIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; WILD TYPE;

ANIMALS; BCG VACCINE; CATTLE; CATTLE DISEASES; DNA PRIMERS; FLOW CYTOMETRY; INTERFERON-GAMMA; MYCOBACTERIUM BOVIS; POLYMERASE CHAIN REACTION; TUBERCULIN TEST; TUBERCULOSIS, BOVINE;

ANIMALIA; BOS; BOVINAE; MYCOBACTERIUM BOVIS;

EID: 84870896521     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051396     Document Type: Article

References (43)

1. Waters WR, Palmer MV, Buddle BM, Vordermeier HM (2012) Bovine tuberculosis vaccine research: historical perspectives and recent advances. Vaccine 30: 2611-2622. S0264-410X(12)00183-1 [pii];10.1016/j.vaccine.2012.02.018 [doi].
2. Buddle BM, Aldwell FE, de Lisle GW, Vordermeier HM, Hewinson RG, et al.(2011) Low oral BCG doses fail to protect cattle against an experimental challenge with Mycobacterium bovis. Tuberculosis (Edinb) 91: 400-405. S1472-9792(11)00126-0 [pii];10.1016/j.tube.2011.07.001 [doi].
3. Hope JC, Thom ML, McAulay M, Mead E, Vordermeier HM, et al. (2011) Identification of surrogates and correlates of protection in protective immunity against Mycobacterium bovis infection induced in neonatal calves by vaccination with M. bovis BCG Pasteur and M. bovis BCG Danish. Clin Vaccine Immunol 18: 373-379. CVI.00543-10 [pii];10.1128/CVI.00543-10 [doi].
4. Lopez-Valencia G, Renteria-Evangelista T, Williams JJ, Licea-Navarro A, Mora-Valle AL, et al. (2010) Field evaluation of the protective efficacy of Mycobacterium bovis BCG vaccine against bovine tuberculosis. Res Vet Sci 88: 44-49. S0034-5288(09)00147-7 [pii];10.1016/j.rvsc.2009.05.022 [doi].
5. Maue AC, Waters WR, Palmer MV, Nonnecke BJ, Minion FC, et al. (2007) An ESAT-6:CFP10 DNA vaccine administered in conjunction with Mycobacterium bovis BCG confers protection to cattle challenged with virulent M. bovis. Vaccine 25: 4735-4746. S0264-410X(07)00414-8 [pii];10.1016/j.vaccine.2007.03.052 [doi].
6. Hu XD, Yu DH, Chen ST, Li SX, Cai H (2009) A combined DNA vaccine provides protective immunity against Mycobacterium bovis and Brucella abortus in cattle. DNA Cell Biol 28: 191-199. 10.1089/dna.2008.0790 [doi].
7. Skinner MA, Wedlock DN, de Lisle GW, Cooke MM, Tascon RE, et al. (2005) The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis. Infect Immun 73: 4441-4444. 73/7/4441 [pii];10.1128/IAI.73.7.4441-4444.2005 [doi].
8. Wedlock DN, Denis M, Painter GF, Ainge GD, Vordermeier HM, et al. (2008) Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone. Clin Vaccine Immunol 15: 765-772. CVI.00034-08 [pii];10.1128/CVI.00034-08 [doi].
9. Wedlock DN, Denis M, Skinner MA, Koach J, de Lisle GW, et al. (2005) Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone. Infect Immun 73: 3540-3546. 73/6/3540 [pii];10.1128/IAI.73.6.3540-3546.2005 [doi].
10. Vordermeier HM, Villarreal-Ramos B, Cockle PJ, McAulay M, Rhodes SG, et al. (2009) Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect Immun 77: 3364-3373. IAI.00287-09 [pii];10.1128/IAI.00287-09 [doi].
11. Wiker HG, Harboe M, (1992) The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev 56: 648-661.
12. Horwitz MA, Lee BW, Dillon BJ, Harth G, (1995) Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 92: 1530-1534.
13. Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan PJ, et al. (1997) Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 276: 1420-1422.
14. Armitige LY, Jagannath C, Wanger AR, Norris SJ, (2000) Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages. Infect Immun 68: 767-778.
15. McMurray DN (2011) Do new TB vaccines have a place in the Expanded Program on Immunization? Expert Rev Vaccines 10: 1675-1677. 10.1586/erv.11.144 [doi].
16. Cataldi AA, Bigi F, Modh-Nor N, Sarmiento ME, Acosta A (2010) Strategies for new Generation Vaccine Development. In: In: Mohd Nor N, Acosta A, Sarmineto ME, editors. The Art & Science of Tuberculosis Vaccine Development. Finlay Instituto, La Havana Cuba Oxford Unversity Press.
17. Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic S (2006) A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG. Vaccine 24: 1593-1600. S0264-410X(05)01037-6 [pii];10.1016/j.vaccine.2005.10.002 [doi].
18. Borsuk S, Mendum TA, Fagundes MQ, Michelon M, Cunha CW, McFadden J, et al.(2007) Auxotrophic complementation as a selectable marker for stable expression of foreign antigens in Mycobacterium bovis BCG. Tuberculosis (Edinb) 87: 474-480. S1472-9792(07)00087-X [pii];10.1016/j.tube.2007.07.006 [doi].
19. Meikle V, Bianco MV, Blanco FC, Gioffre A, Garbaccio S, et al. (2011) Evaluation of pathogenesis caused in cattle and guinea pig by a Mycobacterium bovis strain isolated from wild boar. BMC Vet Res 7: 37. 1746-6148-7-37 [pii];10.1186/1746-6148-7-37 [doi].
20. Wedlock DN, Denis M, Painter GF, Ainge GD, Vordermeier HM, et al. (2008) Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone. Clin Vaccine Immunol 15: 765-772. CVI.00034-08 [pii];10.1128/CVI.00034-08 [doi].
21. Blanco FC, Schierloh P, Bianco MV, Caimi K, Meikle V, et al.(2009) Study of the immunological profile towards Mycobacterium bovis antigens in naturally infected cattle. Microbiol Immunol 53: 460-467. MIM141 [pii];10.1111/j.1348-0421.2009.00141.x [doi].
22. Pfaffl MW, Horgan GW, Dempfle L, (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36.
23. Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic' S (2000) Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci USA 97: 13853-13858. 10.1073/pnas.250480397 [doi];250480397 [pii].
24. Horwitz MA, Harth G, (2003) A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis. Infect Immun 71: 1672-1679.
25. Qie YQ, Wang JL, Liu W, Shen H, Chen JZ, et al. (2009) More vaccine efficacy studies on the recombinant Bacille Calmette-Guerin co-expressing Ag85B, Mpt64 and Mtb8.4. Scand J Immunol 69: 342-350. SJI2231 [pii];10.1111/j.1365-3083.2009.02231.x [doi].
26. Horwitz MA (2005) Recombinant BCG expressing Mycobacterium tuberculosis major extracellular proteins. Microbes Infect 7: 947-954. S1286-4579(05)00139-5 [pii];10.1016/j.micinf.2005.04.002 [doi].
27. Badell E, Nicolle F, Clark S, Majlessi L, Boudou F, et al. (2009) Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells. Vaccine 27: 28-37. S0264-410X(08)01423-0 [pii];10.1016/j.vaccine.2008.10.034 [doi].
28. Seixas FK, Borsuk S, Fagundes MQ, Hartwig DD, Da Silva EF, et al. (2010) Stable expression of Leptospira interrogans antigens in auxotrophic Mycobacterium bovis BCG. Biol Res 43: 13-18. S0716-97602010000100003 [pii];/S0716-97602010000100003 [doi].
29. Bastos RG, Borsuk S, Seixas FK, Dellagostin OA (2009) Recombinant Mycobacterium bovis BCG. Vaccine 27: 6495-6503. S0264-410X(09)01220-1 [pii];10.1016/j.vaccine.2009.08.044 [doi].
30. Mederle I, Bourguin I, Ensergueix D, Badell E, Moniz-Peireira J, et al. (2002) Plasmidic versus insertional cloning of heterologous genes in Mycobacterium bovis BCG: impact on in vivo antigen persistence and immune responses. Infect Immun 70: 303-314.
31. Bange FC, Brown AM, Jacobs WR Jr, (1996) Leucine auxotrophy restricts growth of Mycobacterium bovis BCG in macrophages. Infect Immun 64: 1794-1799.
32. Buddle BM, Wedlock DN, Denis M, Skinner MA (2005) Identification of immune response correlates for protection against bovine tuberculosis. Vet Immunol Immunopathol 108: 45-51. S0165-2427(05)00241-2 [pii];10.1016/j.vetimm.2005.08.002 [doi].
33. Thacker TC, Palmer MV, Waters WR (2007) Associations between cytokine gene expression and pathology in Mycobacterium bovis infected cattle. Vet Immunol Immunopathol 119: 204-213. S0165-2427(07)00168-7 [pii];10.1016/j.vetimm.2007.05.009 [doi].
34. Vordermeier HM, Chambers MA, Cockle PJ, Whelan AO, Simmons J, et al. (2002) Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun 70: 3026-3032.
35. Lindenstrom T, Agger EM, Korsholm KS, Darrah PA, Aagaard C, et al. (2009) Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J Immunol 182: 8047-8055. 182/12/8047 [pii];10.4049/jimmunol.0801592 [doi].
36. Nambiar JK, Pinto R, Aguilo JI, Takatsu K, Martin C, et al. (2012) Protective immunity afforded by attenuated, PhoP-deficient Mycobacterium tuberculosis is associated with sustained generation of CD4+ T-cell memory. Eur J Immunol 42: 385-392. 10.1002/eji.201141903 [doi].
37. Aagaard C, Hoang T, Dietrich J, Cardona PJ, Izzo A, et al. (2011) A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med 17: 189-194. nm.2285 [pii];10.1038/nm.2285 [doi].
38. Whelan AO, Villarreal-Ramos B, Vordermeier HM, Hogarth PJ (2011) Development of an antibody to bovine IL-2 reveals multifunctional CD4 T(EM) cells in cattle naturally infected with bovine tuberculosis. PLoS One 6: e29194. 10.1371/journal.pone.0029194 [doi];PONE-D-11-20403 [pii].
39. Lanzavecchia A, Sallusto F (2005) Understanding the generation and function of memory T cell subsets. Curr Opin Immunol 17: 326-332. S0952-7915(05)00054-3 [pii];10.1016/j.coi.2005.04.010 [doi].
40. Buddle BM, Aldwell FE, Skinner MA, de Lisle GW, Denis M, et al. (2005) Effect of oral vaccination of cattle with lipid-formulated BCG on immune responses and protection against bovine tuberculosis. Vaccine 23: 3581-3589. S0264-410X(05)00257-4 [pii];10.1016/j.vaccine.2005.01.150 [doi].
41. Vordermeier M, Jones GJ, Whelan AO (2011) DIVA reagents for bovine tuberculosis vaccines in cattle. Expert Rev Vaccines 10: 1083-1091. 10.1586/erv.11.22 [doi].
42. Flores-Villalva S, Suarez-Guemes F, Espitia C, Whelan AO, Vordermeier M, et al. (2012) Specificity of the tuberculin skin test is modified by use of a protein cocktail containing ESAT-6 and CFP-10 in cattle naturally infected with Mycobacterium bovis. Clin Vaccine Immunol 19: 797-803. CVI.05668-11 [pii];10.1128/CVI.05668-11 [doi].
43. Waters WR, Palmer MV, Thacker TC, Davis WC, Sreevatsan S, et al. (2011) Tuberculosis immunity: opportunities from studies with cattle. Clin Dev Immunol 2011: 768542. 10.1155/2011/768542 [doi].